Approval · Notice of Compliance 22662 · 2019
NERLYNX: Notice of Compliance 22662
Issued September 18, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22662
- Date
- September 18, 2019
- Company
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NERLYNX | 02490536 | Marketed |
Medicinal ingredients
- NERATINIB MALEATE 40 MG per TAB